Abstract
The significance of tumor angiogenesis has been recognized for many centuries. Fallopio in the 1600s stated “cancers have dilated swollen veins resembling the legs of a crab, and this I single out from many signs since if its cure is undertaken the man nevertheless dies of the same cancer.” However, it has only been since the turn of the century that continual and widespread research has been been performed, and it was not until the 1970s when Folkman and colleagues aroused interest in pathological angiogenesis that the first attempt was made to generate a systematic method for quantifying angiogenesis. The score was based on the assessment of several morphological parameters of “endothelial cell regeneration” stained by routine histological methods. Named the MAGS score (Microscopic Angiogenesis Grading System), it assessed the number of vessels, the degree of endothelial-cell hyperplasia, and the cytology of the tumor endothelium (1). The aim was to develop an objective method for quantifying the tumor neovasculature that could be used as a standard for angiogenesis reasearch, to compare with other clinicopathological characteristics and be useful in the development and assessment of efficacy of anti-angiogenic agents and vascular targeting therapies (2). However, many of the difficulties that still impede the clinical utility of angiogenesis quantitation systems today, including problems of tissue-sample selection, inter- and intraobserver variation, were such that the technique was not adopted. Further attempts to assess tumor angiogenesis were carried out using a variety of nonspecific endothelial markers but it has been only in the last five years, with the advent of highly specific endothelial markers (3–5) that can be used in histological archival tissues, that quantitation studies have been performed. As indicated earlier, there are still limitations to the current methodologies for measuring tumor angiogenesis but new methods are continually being assessed (see below). Furthermore, many of these mght have potential supplementary clinical uses such as in diagnosis, prediction of treatment response, and monitoring of disease status. Such methods might also be applied to other common and debilitating diseases such as psoriasis, rheumatoid arthritis (RA), atherosclerosis, and diabetic retinopathy where angiogenesis is central to the pathological process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brem, S., Cotran, R., and Folkman, J. (1972) Tumor angiogenesis: a quantitative method for histological grading. J. Natl. Cancer Inst. 48, 34–356.
Folkman, J. (1971) Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 82–86.
Mlynek, M., van Beunigen, D., Leder, L.-D., and Streffer, C. (1985) Measurement of the grade of vascularisation in histological tumor tissue sections. Br. J. Cancer 52, 945–948.
Svrivastava, A., Laidler, P., Davies, R., Horgan, K., and Hughes, L. (1988) The prognostic significance of tumor vascularity in intermediate thickness (0.76–4.0mm thick) skin melanoma. Am. J. Pathol. 133, 419–423.
Porschen, R., Classen, S., Piontek, M., and Borchard, F. (1994) Vascularization of carcinomas of the esophagus and its correlation with tumor proliferation. Cancer Res. 54, 587–91.
Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. (1991) Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1–8.
Page, D. L. and Dupont, W. D. (1992) Breast cancer angio-histogenesis: through a narrow window [editorial; comment]. J. Natl. Cancer Inst. 84, 1850–1851.
Page, D. and Jensen, R. (1995) Angiogenesis in human breast carcinoma. Human Pathol. 26, 1173–1174.
Protopapa, E., Delides, G. S., and Revesz, L. (1993) Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy. Eur. J. Cancer. 29A, 1141–1145.
Wakui, S., Furusato, M., Itoh, T., Sasaki, H., Akiyama, A., Kinoshita, I., (1992) Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastases: a morphometric study. J. Pathol. 168, 257–262.
Carnochan, P., Briggs, J. C., Westbury, G., and Davies, A. J. (1991) The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85–1.25 mm in thickness. Br. J. Cancer 64, 102–107.
Barnhill, R. L., Fandrey, K., Levy, M. A., Mihm, M. J., and Hyman, B. (1992) Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab. Invest. 67, 331–337.
Visscher, D., Smilanetz, S., Drozdowicz, S., and Wykes, S. (1993) Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Anal. Quant. Cytol. 15, 88–92.
Visscher, D., DeMattia, F., and Boman, S. (1994) Technical factors affecting image morphometric microvessel density counts in breast carcinomas. Lab. Invest. 70, 168A (abstract).
Vesalainen, S., Lipponen, P., Talja, M., Alhava, E., and Syrjanen, K. (1994) Tumor vascularity and basement membrane structure as prognostic factors in T1–2M0 prostatic adenocarcinoma. Anticancer Res. 14, 709–714.
Kuzu, I., Bicknell, R., Harris, A. L., Jones, M., Gatter, K. C., and Mason, D. Y. (1992) Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumors. J. Clin. Pathol. 45, 143–148.
Schlingemann, R. O., Rietveld, F. J., Kwaspen, F., van, d. K. P., de, W. R., and Ruiter, D. J. (1991) Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am. J. Pathol. 138, 1335–1347.
Page, C., Rose, M., Yacoub, M., and Pigott, R. (1992) Antigenic heterogeneity of vascular endothelium. Am. J. Pathol. 141, 673–683.
Horak, E. R., Leek, R., Klenk, N., LeJeune, S., Smith, K., Stuart, N.,(1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340, 1120–1124.
Parums, D., Cordell, J., Micklem, K., Heryet, A., Gatter, K., and Mason, D. (1990) JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol. 43, 752–757.
Dickinson, A. J., Fox, S. B., Persad, R. A., Hollyer, J., Sibley, G. N., and Harris, A. L. (1994) Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br. J. Urol. 74, 762–766.
Fox, S., Leek, R., Smith, K., Hollyer, J., Greenall, M., and Harris, A. (1994) Tumor angiogenesis in node negative breast carcinomas-relationship to epidermal growth factor receptor and survival. Breast Cancer Res. Treat. 29, 109–116.
Toi, M., Kashitani, J., and Tominaga, T. (1993) Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int. J. Cancer. 55, 371–374.
Siitonen, S., Haapasalo, H., Rantala, I., Helin, H., and Isola, J. (1995) Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod. Pathol. 8, 745–752.
Tanigawa, N., Matsumura, M., Amaya, H., Kitaoka, A., Shimomatsuya, T., Lu, C., (1997) Tumor vascularity correlates with the prognosis of patients with esophageal squamous carcinoma. Cancer 79, 220–225.
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84, 1875–1887.
Weidner, N., Gasparini, G., Bevilacqua, P., Maluta, S., Palma, P., Caffo, O., (1994) Tumor microvessel density, p53 expression, and tumor size are relevant prognostic markers in node negative breast carcinomas. Lab. Invest. 70, A24 (abstract).
Burrows, F. J. and Thorpe, P. E. (1994) Vascular targeting: a new approach to the therapy of solid tumors. Pharmacol. Ther. 64, 155–174.
Wang, J. M., Kumar, S., Pye, D., Haboubi, N., and Al-Nakib, L. (1994) Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. J. Natl. Cancer Inst. 86, 386–388.
Kaczmarek, J., Castellani, P., Nicolo, G., Spina, B., Allemanni, G., and Zardi, L. (1994) Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int. J. Cancer 58, 11–16.
Fox, S., Gatter, K., Bicknell, R., Going, J., Stanton, P., Cooke, T., and Harris, A. (1993) Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res. 53, 9161–9163.
Fox, S., Turner, G., Gatter, K., and Harris, A. (1995) The increased expression of adhesion molecules ICAM-3, E and P selectin on breast cancer endothelium. J. Pathol. 177, 369–376.
Van Hoef, M. E., Knox, W. F., Dhesi, S. S., Howell, A., and Schor, A. M. (1993) Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur. J. Cancer 29A, 1141–1145.
Hall, N. R., Fish, D. E., Hunt, N., Goldin, R. D., Guillou, P. J., and Monson, J. R. (1992) Is the relationship between angiogenesis and metastasis in breast cancer real? Surg. Oncol. 1, 223–229.
Sahin, A., Sneige, N., Singletary, E., and Ayala, A. (1992) Tumor angiogenesis detected by Factor-VIII immunostaining in node-negative breast carcinoma (NNBC): a possible predictor of distant metastasis. Mod. Pathol. 5, 17A (abstract).
Sightler, H., Borowsky, A., Dupont, W., Page, D., and Jensen, R. (1994) Evaluation of tumor angiogenesis as a prognostic marker in breast cancer. Lab. Invest. 70, 22A (abstract).
Fox, S. B., Leek, R. D., Weekes. M P, Whitehouse, R. M., Gatter, K. C., and Harris, A. L. (1995) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J. Pathol. 177, 275–283.
Axelsson, K., Ljung, B., Moore II, D., Thor, A., Chew, K., Edgerton, S., (1995) Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J. Natl. Cancer Inst. 87.
Barbareschi, M., Weidner, N., Gasparini, G., Morelli, L., Forti, S., Eccher, C., (1995) Microvessel quantitation in breast carcinomas. Appl. Immunochem. 3, 75–84.
Simpson, J., Ahn, C., Battifora, H., and Esteban, J. (1994) Vascular surface area as a prognostic indicator in invsasive breast carcinoma. Lab. Invest. 70, 22A.
Brawer, M. K., Deering, R. E., Brown, M., Preston, S. D., and Bigler, S. A. (1994) Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 73, 678–687.
Furusato, M., Wakui, S., Sasaki, H., Ito, K., and Ushigome, S. (1994) Tumor angiogenesis in latent prostatic carcinoma. Br. J. Cancer 70, 1244–1246.
Bigler, S., Deering, R., and Brawer, M. (1993) Comparisons of microscopic vascularity in benign and malignant prostate tissue. Human Pathol. 24, 220–226.
Williams, J K, Carlson, G. W., Cohen, C., Derose, P. B., Hunter, S., and Jurkiewicz, M. J. (1994) Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am. J. Surg. 168, 373–380.
Wesseling, P., Vandersteenhoven, J. J., Downey, B. T., Ruiter, D. J., and Burger, P. C. (1993) Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms. A light microscopic and immunohistochemical study of formalin-fixed, routinely processed material. Acta. Neuropathol. (Berl.) 85, 508–514.
Charpin, C., Devictor, B., Bergeret, D., Andrac, L., Boulat, J., Horschowski, N., (1995) CD31 Quantitative immunocytochemical assays in breast carcinomas. Am. J. Clin. Pathol. 103, 443–448.
Fox, S., Turner, G., Leek, R., Whitehouse, R., Gatter, K., and Harris, A. (1995) The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Br. Cancer Res. Treat. 36, 219–226.
Chalkley, H. (1943) Method for the quantative morphological analysis of tissues. J. Natl. Cancer Inst. 4, 47–53.
Bosari, S., Lee, A. K., DeLellis, R. A., Wiley, B. D., Heatley, G. J., and Silverman, M. L. (1992) Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol. 23, 755–761.
Guinebretiere, J. M., Le, M. G., Gavoille, A., Bahi, J., and Contesso, G. (1994) Angiogenesis and risk of breast cancer in women with fibrocystic disease [letter]. J. Natl. Cancer Inst. 86, 635–636.
Olivarez, D., Ulbright, T., DeRiese, W., Foster, R., Reister, T., Einhorn, L., and Sledge, G. (1994) Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease. Cancer Res. 54, 2800–2802.
Bundred, N., Bowcott, M., Walls, J., Faragher, E., and Knox, F. (1994) Angiogenesis in breast cancer predicts node metastasis and survival. Br. J. Surg. 81, 768 (Abstract).
Costello, P., McCann, A., Carney, D. N., and Dervan, P. A. (1995) Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum. Pathol. 26, 1181–1184.
Paweletz, N. and Knierim, M. (1989) Tumor-related angiogenesis. Crit. Rev. Oncol. Hematol. 9, 197–242.
Blood, C. H. and Zetter, B. R. (1990) Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta. 1032, 89–118.
Bicknell, R. and Harris, A. L. (1991) Novel growth regulatory factors and tumor angiogenesis. Eur. J. Cancer 27, 781–785.
Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res. 55, 3964–3968.
Brown, D. M., Hong, S. P., Farrell, C. L., Pierce, G. F., and Khouri, R. K. (1995) Platelet-derived growth factor BB induces functional vascular anastomoses in vivo. Proc. Natl. Acad. Sci. USA 92, 5920–5924.
Moghaddam, A., Zhang, H. T., Fan, T. P., Hu, D. E., Lees, V. C., Turley, H., (1995) Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA 92, 998–1002.
Anandappa, S. Y., Winstanley, J. H., Leinster, S., Green, B., Rudland, P.S., andBarraclough, R. (1994) Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br. J. Cancer 69, 772–776.
Reynolds, K., Farzaneh, F., Collins, W. P., Campbell, S., Bourne, T. H., Lawton, F., (1994) Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J. Natl. Cancer Inst. 86, 1234–1238.
Garver, R. J., Radford, D. M., Donis, K. H., Wick, M. R., and Milner, P. G. (1994) Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 74, 1584–1590.
Janot, F., el, N. A., Morrison, R. S., Liu, T. J., Taylor, D. L., and Clayman, G. L. (1995) Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int. J. Cancer 64, 117–123.
Gomm, J J, Smith, J., Ryall, G. K., Ballic, R., Turnbull, L., and Coombes, R. C. (1991) Localisation of basic fibroblast growth factor and transforming growth factor b1 in the human mammary gland. Cancer Res. 51, 4685–4692.
Zarnegar, R. and DeFrances, M. C. (1993) Expression of HGF-SF in normal and malignant human tissues. Exs. 65, 181–199.
Daa, T., Kodama, M., Kashima, K., Yokoyama, S., Nakayama, I., and Noguchi, S. (1993) Identification of basic fibroblast growth factor in papillary carcinoma of the thyroid. Acta Pathol. Jpn. 43, 582–589.
Wong, S. Y., Purdie, A. T., and Han, P. (1992) Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. Am. J. Pathol. 140, 1473–1482.
Schultz-Hector, S. and Haghayegh, S. (1993) B-Fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res. 53, 1444–1449.
Alvarez, J. A., Baird, A., Tatum, A., Daucher, J., Chorsky, R., Gonzalez, A. M. and Stopa, E. G. (1992) Localisation of basic fibroblast growth factor and vascular endothelial cell growth factor in human glial neoplasms. Mod. Pathol. 5, 303–307.
Guidi, A. J., Abu, J. G., Berse, B., Jackman, R. W., Tognazzi, K., Dvorak, H. F., and Brown, L. F. (1995) Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J. Natl. Cancer Inst. 87, 1237–1245.
Zagzag, D., Brem, S., and Robert, F. (1988) Neovascularization and tumor growth in the rabbit brain. A model for experimental studies of angiogenesis and the blood-brain barrier. Am. J. Pathol. 131, 361–372.
Visscher, D. W., DeMattia, F., Ottosen, S., Sarkar, F. H., and Crissman, J. D. (1995) Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma. Mod. Pathol. 8, 665–670.
Mattern, J., Koomagi, R., and Volm, M. (1996) Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer 73, 931–934.
Viglietto, G., Romano, A., Maglione, D., Rambaldi, M., Paoletti, I., Lago, C., (1996) Neovascularisation in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta growth factor. Oncogene 13, 577–587.
Toi, M., Hoshina, S., Takayanagi, T., and Tominaga, T. (1994) Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res. 85, 1045–1049.
Takano, S., Yoshii, Y., Kondo, S., Suzuki, H., Maruno, T., Shira, S., and Nose, T. (1996) Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 56, 2185–2190.
O’Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. (1995) Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 55, 510–513.
Maeda, K., Chung, Y. S., Ogawa, Y., Kang, S., Takatsuka, S., Ogawa, M., Sawada, T., and Sowa, M. (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77, 858–863.
Inoue, K., Ozeki, Y., Suganuma, T., Sugiura, Y., and Tanaka, S. (1996) Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma-assocation with angiogenesis and tumor progression. Cancer 79, 206–213.
Ohta, Y., Endo, Y., Tanaka, M., Shimizu, J., Oda, M., Hayashi, Y., (1996) Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin. Cancer Res. 2, 1411–1416.
Toi, M., Hoshina, S., Taniguchi, T., Yamamoto, Y., Ishitsuka, H., and Tominaga, T. (1995) Expression of platelet derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int. J. Cancer 64, 79–82.
Takahashi, Y., Bucana, C., Liu, W., Yoneda, J., Kitadai, Y., Cleary, K. R., and Ellis, L. M. (1996) Platelet-derived endothelial cell growth factor in human colon angiogenesis: role of infiltrating cells. J. Natl. Cancer Inst. 88, 1146–1151.
Takebayashi, Y., Akiyama, S., Akiba, S., Yamada, K, Miyadera, K., Sumizawa, T., (1996) Clinicpathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst. 88, 1110–1117.
Fox, S. B., Westwood, M., Moghaddam, A., Comley, M., Turley, H., Whitehouse, R. M., (1996) The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br. J. Cancer 73, 275–280.
Fujimoto, K., Ichimori, Y., Kakizoe, T., Okajima, E., Sakamoto, H., Sugimura, T., and Terada, M. (1991) Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem. Biophys. Res. Comm. 180, 386–392.
Kondo, S., Asano, M., Matsuo, K., Ohmori, I., and Suzuki, H. (1994) Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta 1221, 211–214.
Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst. 86, 356–361.
Li, V., Folkerth, R., Watanabe, H., Yu, C., Rupnick, M., Barnes, P., (1994) Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumors. Lancet 344, 82–86.
Kendall, R. L. and Thomas, K. A. (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl..Acad. Sci. USA 90, 10,705–10, 709.
Good, D. J., Polverini, P. J., Rastinejad, F., Le, B. M., Lemons, R. S., Frazier, W. A., and Bouck, N. P. (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87, 6624–6628.
Rastinejad, F., Polverini, P. J., and Bouck, N. P. (1989) Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345–355.
Van Meir, E. G., Polverini, P. J., Chazin, V. R., Su Huang, H. J., de Tribolet, N., and Cavenee, W. K. (1994) Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat. Genet. 8, 171–176.
O’Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328.
Zabrenetzky, V., Harris, C. C., Steeg, P. S., and Roberts, D. (1994) Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int. J. Cancer 59, 191–195.
Weinstat-Saslow, D. L., Zabrenetzky, V. S., Van, H. K., Frazier, W. A., Roberts, D. D., and Steeg, P. S. (1994) Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res. 54, 6504–6511.
Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582–1584.
Volpert, O., Tolsma, S., Pellerin, S., Feige, J., Chen, H., Mosher, D., and Bouck, N. (1995) Inhibition of angiogenesis by thrombospondin-2. Biochim. Biophys. Res. Comm. 217, 326–332.
Vlodaysky, I., Korner, G., Ishai, M. R., Bashkin, P., Bar, S. R., and Fuks, Z. (1990) Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev. 9, 203–226.
Hanneken, A., Maher, P., and Baird, A. (1995) High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells-implications for the modulation of FGF-2. J. Cell Biol. 128, 1221–1228.
Friesel, R. E. and Maciag, T. (1995) Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9, 919–925.
Pepper, M. and Montesano, R. (1990) Proteolytic balance and capillary morphogenesis. Cell Diff. Dey. 32, 319–328.
Fisher, C., Gilbertson, B. S., Powers, E. A., Petzold, G., Poorman, R., and Mitchell, M. A. (1994) Interstitial collagenase is required for angiogenesis in vitro. Del/. Biol. 162, 499–510.
Grondahl-Hansen, J., Christensen, I. J., Rosenquist, C., Brunner, N., Mouridsen, H. T., Dano, K., and Blichert, T. M. (1993) High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res. 53, 2513–2521.
Janicke, F., Schmitt, M., Pache, L., Ulm, K., Harbeck, N., Hofler, H., and Graeff, H. (1993) Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res. Treat. 24, 195–208.
Foekens, J. A., Schmitt, M., van, P. W., Peters, H. A., Bontenbal, M., Janicke, F., and Klijn, J. G. (1992) Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res. 52, 6101–6105.
Duffy, M. J., Reilly, D., O’Sullivan, C., O’Higgins, N., Fennelly, J. J., and Andreasen, P. (1990) Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res. 50, 6827–6829.
Schmitt, M., Janicke, F., Moniwa, N., Chucholowski, N., Pache, L., and Graeff, H. (1992) Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. Biol. Chem. Hoppe Seyler 373, 611–622.
Spyratos, F., Martin, P. M., Hacene, K., Romain, S., Andrieu, C., Ferrero, P. M., (1992) Multiparametric prognostic evaluation of biological factors in primary breast cancer. J. Natl. Cancer Inst. 84, 1266–1272.
Sumiyoshi, K., Serizawa, K., Urano, T., Takada, Y., Takada, A., and Baba, S. (1992) Plasminogen activator system in human breast cancer. Int. J. Cancer 50, 345–348.
Ganesh, S., Sier, C. F. M., Heerding, M. M., Griffioen, G., Lamers, C. B. H. W., and Verspaget, H. W. (1994) Urokinase receptor and colorectal cancer survival. Lancet 344, 401–402.
Hildenbrand, R., Dilger, I., Horlin, A., and Stutte, H. J. (1995) Urokinase plasminogen activator induces angiogenesis and tumor vessel invasion in breast cancer. Pathol. Res. Pract. 191, 403–409.
Nguyen, M., Strubel, N. A., and Bischoff, J. (1993) A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365, 267–269.
Kaplanski, G., Farnarier, C., Benoliel, A., Foa, C., Kaplanski, S., and Bongrand, P. (1994) A novel role for E- and P-selectins: shape of endothelial cell monolayers. J. Cell Sci. 107, 2449–2457.
Koch, A., Halloran, M. M., Haskell, C. J., Shah, M. R., and Polverini, P. J. (1995) Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376, 517–519.
Leavesley, D. I., Schwartz, M. A., Rosenfeld, M., and Cheresh, D. A. (1993) Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell Biol. 121, 163–170.
Davis, C. M., Danehower, S. C., Laurenza, A., and Molony, J. L. (1993) Identification of a role of the vitronectin receptor and protein kinase C in the induction of endothelial cell vascular formation. J. Cell Biochem. 51, 206–218.
Bauer, J., Margolis, M., Schreiner, C., Edgell, C. J., Azizkhan, J, Lazarowski, E., and Juliano, R. L. (1992) In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins. J. Cell Physiol. 153, 437–449.
Luscinskas, F. W. and Lawler, J. (1994) Integrins as dynamic regulators of vascular function. FASEB J. 8, 929–938.
Brooks, P. C., Clark, R. A., and Cheresh, D. A. (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264, 569–571.
Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164.
Brooks, P. C., Stromblad, S., Klemke, R., Visscher, D., Sarkar, F. H., and Cheresh, D. A. (1995) Antiintegrin [33av blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96, 1815–1822.
Gamble, J. R., Matthias, L. J., Meyer, G., Kaur, P., Russ, G., Faull, R., (1993) Regulation of in vitro capillary tube formation by anti-integrin antibodies. J. Cell Biol. 121, 931–943.
Jackson, C. J., Knop, A., Giles, I., Jenkins, K, and Schrieber, L. (1994) VLA-2 mediates the interaction of collagen with endothelium during in vitro vascular tube formation. Cell Biol. Int. 18, 859–867.
Zocchi, M. R. and Poggi, A. (1993) Lymphocyte-endothelial cell adhesion molecules at the primary tumor site in human lung and renal cell carcinomas [letter]. J. Natl. Cancer Inst. 85, 246–247.
Dvorak, H. F. (1987) Thrombosis and cancer. Hum. Pathol. 18, 275–284.
Palabrica, T., Lobb, R., Furie, B. C., Aronovitz, M., Benjamin, C., Hsu, Y. M.,(1992) Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359, 848–851.
Schadendorf, D., Heidel, J., Gawlik, C., Suter, L., and Czarnetzki (1995) Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J. Natl. Cancer Inst. 87, 366–371.
Kageshita, T., Yoshii, A., Kimura, T., Kuriya, N., Ono, T., Tsujisaki, M., (1993) Clinical relevance of ICAM-1 expression in prmary lesions and serum of patients with malignant melanoma. Cancer Res. 53, 4927–4932.
Banks, R. E., Gearing, A. J., Hemingway, I. K., Norfolk, D. R., Perren, T. J., and Selby, P. J. (1993) Circulating intercellular adhesion molecule-1 (ICAM-1), malignancies. Br. J. Cancer 68, 122–124.
Bauer, H. C., Steiner, M., and Bauer, H. (1992) Embryonic development of the CNS microvasculature in the mouse: new insights into the structural mechanisms of early angiogenesis. Exs 61, 64–68.
Gamble, J. R., Khew, G. Y., and Vadas, M. A. (1993) Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J. Immunol. 150, 4494–4503.
Warren, T., Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Feder, J., Connolly, D. T. (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309–1312.
Paku, S. and Lapis, K. (1993) Morphological aspects of angiogenesis in experimental liver metastases. Am. J. Pathol. 143, 926–936.
Lauk, S., Zietman, A., Skates, S., Fabian, R., and Suit, H. D. (1989) Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice. Cancer Res. 49, 4557–4561.
Smolle, J., Soyer, H. P., Hofmann-Wellenhof, Smolle-Juettner, F. M., and Kerl, H. (1989) Vascular architecture of melanocytic skin tumors. Path. Res. Pract. 185, 740–745.
Cockerell, C. J., Sonnier, G., Kelly, L., and Patel, S. (1994) Comparative analysis of neovascularisation in primary cutaneous melanoma and Spitz nevus. Am. J. Dermatopathol. 16, 9–13.
Folberg, R., Rummelt, V., Ginderdeuren, R.-V., Hwang, T., Woolson, R., Pe’er, J., and Gruman, L. (1993) The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100, 1389–1398.
Jain, R. K. (1994) Barriers to drug delivery in solid tumors. Sci. Am. 271, 58–65.
Vaupel, P., Kallinowski, F., and Okunieff, P. (1990) Blood flow, oxygen consumption and tissue oxygenation of human tumors. Adv. Exp. Med. Biol. 277, 895–905.
Jain, R. K. (1990) Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 9, 253–266.
Mitchell, B. S., Schumacher, U., and Kaiserling, E. (1994) Are tumors innervated? Immunohistological investigations using antibodies against the neuronal marker protein gene product 9.5 (PGP 9.5) in benign, malignant and experimental tumors. Tumor Biol. 15, 269–274.
Nystrom, C., Forssman, L., and Roos, B. (1969) Myometrial blood flow studies in carcinoma of the corpus uteri. Acta Radiol. Ther. 8, 193–198.
Kurjak, A., Salihagic, A., Kupesic, U. S., and Predanic, A. (1992) Clinical value of the assessment of gynaecological tumour angiogenesis by transvaginal colour Doppler. Ann. Med. 24, 97–103.
Frouge, C., Guinbretiere, J., Contesso, G., di Paola, R., and Blery, M. (1994) Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest. Radiol. 29, 1043–1049.
Lee, W. J., Chu, J. S., Houng, S. J., Chung, M. F., Wang, S. M., and Chen, K. M. (1995) Breast cancer angiogenesis: a quantitative morphologic and Doppler imaging study. Ann. Surg. Oncol. 2, 246–251.
Antonic, J. and Rakar, S. (1995) Colour and pulsed doppler US and tumor marker CAl25 in differentiation between benign and malignant ovarian masses. Anticancer Res. 15, 1527–1532.
Wu, C. C., Lee, C. N., Chen, T. M., Shyu, M. K., Hsieh, C. Y., Chen, H. Y., and Hsieh, F. J. (1994) Incremental angiogenesis assessed by color Doppler ultrasound in the tumorigenesis of ovarian neoplasms. Cancer 73, 1251–1256.
Carter, J., Lau, M., Saltzman, A, Hartenbach, E., Chen, M., Johnson, P., (1994) Gray scale and color flow Doppler characterization of uterine tumors. J. Ultrasound Med. 13, 835–840.
Ernst, H., Hahn, E., Balzer, T., Schlief, R., and Heyder, N. (1996) Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. J. Clin. Ultrasound. 24, 31–35.
Huang, S.C., Yu, C. H., Huang, R. T., Hsu, K. F., Tsai, Y. C., and Chou, C. Y. (1996) Intratumoral blood flow in uterine myoma correlated with a lower tumor size and volume, but not correlated with cell proliferation or angiogenesis. Obstet. Gynecol. 87, 1019–1024.
Gilles, R., Zafrani, B., Guinebretiere, J. M., Meunier, M., Lucidarme, O., Tardivon, A. A., (1995) Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 196, 415–419.
Guidi, A., Fischer, L., Harris, J., and Schnitt, S. (1994) Microvessel density and distribution in ductal carcinoma in situ of the breast. J. Natl. Cancer Inst. 86, 614–619.
Engels, K., Fox, S. B., Gatter, K. C., and Hams, A. L. (1995) Distinct angiogenenic patterns are associated with high grade in-situ ductal carcinoma of breast. J. Pathol. 181, 207–212.
Sterns, E., Zee, B., SenGupta, S., and Saunders, F. (1996) Thermography: its relation to pathologic characteristics, vascularity, proliferation rate and survival of patinets with invasive ductal carcinoma of the breast. Cancer 77, 1324–1328.
Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P. (1996) Association between tumor hypoxia and malignant progression in advance cancer of the uterine cervic. Cancer Res. 56, 4509–4515.
Brizel, D., Scully, S., Harrelson, J., Layfield, L., Beach, J., Prosnitz, L., and Dewhitst, M. (1996) Tumor oxygenation profiles for the likelihood of distant metastases in human soft tissue sarcomas. Cancer Res. 56, 941–943.
Shweiki, D., Neeman, M., Itin, A., and Keshet, E. (1995) Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc. Natl. Acad. Sci. USA 92, 768–772.
Brem, S. S., M., J. H. and Gullino, P. M. (1978) Angiogenesis as a marker of pre-neoplastic lesions of the human breast. Cancer 41, 239–248.
Jensen, H. M., Chen, I., DeVault, M. R., and Lewis, A. E. (1982) Angiogenesis induced by “normal” human breast tissue: a probable marker for precancer. Science 218, 293–295.
Chodak, G. W., Haudenschild, C., Gittes, R. F., and Folkman, J. (1980) Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann. Surg. 192, 762–771.
Fregene, T. A., Kellog, C., and Pienta, K. J. (1994) Microvessel quantitation as a measure of angiogenic activity in benign breast tissues lesions: a marker for precancerous disease ? Int. J. Oncol. 4, 1199–1202.
Heffelfinger, S., Yassin, R., Miller, M., and Lower, E. (1996) Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features. Clin. Cancer Res. 2, 1873–1878.
Montironi, R., Galluzzi, C., Diamanti, L., Taborro, R., Scarpelli, M., and Pisani, E. (1993) Prostatic intra-epithelial neoplasia. Qualitative and qualitative analysis of the blood capillary architecture. Path. Res Pract. 189, 542–548.
Deering, R. E., Bigler, S. A., Brown, M., and Brawer, M. K. (1995) Microvascularity in benign prostatic hyperplasia. Prostate 26, 111–115.
Fox, S. B., Leek, R. D., Smith, K., Hollyer, J., Greenall, M., and Harris, A. L. (1994) Tumor angiogenesis in node-negative breast carcinomas: relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res. Treat. 29, 109–116.
Toi, M., Inada, K., Suzuki, H., and Tominaga, T (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res. Treat. 36, 193–204.
Ogawa, Y., Chung, Y., Nakata, B., Takatsuka, S., Maeda, K., Sawada, T., (1995) Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen. Br. J. Cancer 71, 1297–1301.
Gasparini, G. and Harris, A. L. (1994) Does improved control of tumor growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells? Eur. J. Cancer 30A, 201–206.
Lipponen, P., Ji, H., Aaltomaa, S., and Syrjanen, K. (1994) Tumor vascularity and basement membrane structure in breast cancer as related to tumor histology and prognosis. J. Cancer Res. Clin. Oncol. 120, 645–650.
Smith-McCune, K. and Weidner, N. (1994) Demonstration and characterization of the angiogenic properties of cervival dysplasia. Cancer Res. 54, 800–804.
Wiggins, D. L., Granai, C. O., Steinhoff, M. M., and Calabresi, P. (1995) Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol. Oncol. 56, 353–356.
Palczak, R. and Splawinski, J. (1989) Angiogenic activity and neovascularization in adenocarcinoma of endometrium. Int. J. Gynaecol. Obstet. 29, 343–357.
Hollingsworth, H. C., Kohn, E. C., Steinberg, S. M., Rothenberg, M. L., and Merino, M. J. (1995) Tumor angiogenesis in advanced stage ovarian carcinoma [see comments]. Am. J. Pathol. 147, 33–41.
Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., and Folkman, J. (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143, 401–409.
Hall, M. C., Troncoso, P., Pollack, A., Zhau, H. Y., Zagars, G. K., Chung, L. W., and von, E. A. (1994) Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology 44, 869–875.
Jaeger, T., Weidner, N., Chew, K., Moore, D., Kerschman, R., Waldman, F., and Carrol, P. (1995) Tumor angiogenesis correlates with lymph node metastasis in invasive bladder cancer. J. Urol. 154, 69–71.
Macchiarelli, G., Nottola, S. A., Vizza, E., Kikuta, A., Murakami, T., and Motta, P. M. (1991) Ovarian microvasculature in normal and hCG stimulated rabbits. A study of vascular corrosion casts with particular regard to the interstitium. J. Submicrosc. Cytol. Pathol. 23, 391–395.
Giatromanolaki, A., Koukourakis, O’Byrne, K., Fox, S., Whitehouse, R., Talbot, D., (1995) Prognostic value of angiogenesis in operable non-small cell lung cancer. J. Pathol. 179, 80–88.
Maeda, K., Chung, Y. S., Takatsuka, S., Ogawa, Y., Sawada, T., Yamashita, Y., et, al. (1995) Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J. Clin. Oncol. 13, 477–481.
Saclarides, T. J., Speziale, N. J., Drab, E., Szeluga, D. J., and Rubin, D. B. (1994) Tumor angiogenesis and rectal carcinoma. Dis. Colon. ‘Rectum. 37, 921–926.
Klijanienko, J., El-Naggar, A., de Braud, F., Rodriguez-Peralto, J., Rodriguez, R., Itzhaki, M., (1995) Tumor vascularisation, mitotic index, histopathological grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer 75, 1649–1656.
Leedy, D. A., Trune, D. R., Kronz, J. D., Weidner, N., and Cohen, J. I. (1994) Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol. Head Neck Surg. 111, 417–422.
Gasparini, G., Weidner, N., Maluta, S., Pozza, F., Boracchi, P., Mezzetti, M., (1993) Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int. J. Cancer 55, 739–744.
Zatterstrom, U., Brun, E., Willen, R., Kjellen, E., and Wennerberg, J. (1995) Tumor angiogenesis and prognosis in squamous carcinoma of the head and neck. Head Neck 17, 312–318.
Albo, D., Granick, M., Jhala, N., Atkinson, B., and Solomon, M. (1994) The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann. Plast. Surg. 32, 558–594.
Ohsawa, M., Tomita, Y., Kuratsu, S., Kanno, H., and Aozasa, K. (1995) Angiogenesis in malignant fibrous histiocytoma. Oncology 52, 51–54.
Weidner, N. (1995) Intratumoral microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147, 9–19.
Dearnaley, D., Sloane, J., Ormerod, M., Steele, K., Coombes, R., Clink, H., (1981) Increased setection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br. J. Cancer 44, 85–90.
Osborne, M. P., Wong, G. Y., Asina, S., Old, L. J., Cote, R. J., and Rosen, P. P. (1991) Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res. 51, 2706–2709.
Pantel, K., Schlimok, G., Angstwurn, M., Weckermann, D., Schmaus, W., Gath, H., (1994) Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J. Hematother. 3, 165–173.
Gasparini, G., Fox, S., Verderio, P., E., B., Bevilacqua, P., Borrachi, P., Dante, S., (1996) The determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node positive breast cancer patients. Clin. Cancer Res. 2, 1191–1198.
Gasparini, G. and Harris, A. L. (1995) Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. Clin. Oncol. 13, 765–782.
Fox, S., Engels, K., Comley, M., Whitehouse, R., Turley, H., Gatter, K., and Harris, A. (1997) Relationship of elevated tumor thymidine phosphorylase in node positive breast carcinomas to the effects of adjuvant CMF. Ann. Oncol. 8, 271–275.
Larsen, N. S. (1993) Angiogenesis research yields new approaches to cancer treatment and prognosis [news]. J. Natl. Cancer Inst. 85, 1629–1630.
Dixon, J., Kaklamanis, L., Turley, H., Hickson, I. D., Leek, R. D., Harris, A. L., and Gatter, K. C. (1994) Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J. Clin. Pathol. 47, 43–47.
Fina, L., Molgaard, H. V., Robertson, D., Bradley, N. J., Monaghan, P., Delia, D., (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75, 2417–2426.
Silverstein, R. L., Baird, M., Lo, S. K., and Yesner, L. M. (1992) Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor. J. Biol. Chem. 267, 16,607–16, 612.
Wellicome, S. M., Thornhill, M. H., Pitzalis, C., Thomas, D. S., Lauchbury, J. S., Panayi, G. S., and Haskard, D. O. (1990) A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J. Immunol. 144, 2558–2565.
Metzelaar, M. J., Schuurman, H. J., Heijnen, H. F., Sixma, J. J., and Nieuwenhius, H. K. (1991) Biochemical and immunohistochemical characteristics of CD62 and CD63 monoclonal antibodies. Expression of GMP-140 and LIMP-CD63 (CD63 antigen) in human lymphoid tissues. Virchows Arch. B Cell. Pathol. 61, 269–277.
de Fougerolles, A., Stacker, S. A., Schwarting, R., and Springer, T. A. (1991) Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J. Exp. Med. 174, 253–267.
Kuzu, I., Bicknell, R., Fletcher, C. D., and Gatter, K. C. (1993) Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab. Invest. 69, 322–328.
Rettig, W. J., Garin, C. P., Healey, J. H., Su, S. L., Jaffe, E. A., and Old, L. J. (1002) Indentification of endosialin, a cell surface gylcoprotein of vascular endothelial cells in human cancer. Proc. Natl. Acad. Sci. USA 89, 10,832–10, 836.
Hagemeier, H. H., Vollmer, E., Goerdt, S., Schulze, O. K., and Sorg, C. (1986) A monoclonal antibody reacting with endothelial cells og budding vessels in tumors and inflammatory tissues, and non-reactive with normal adult tissues. Int. J. Cancer 38, 481–488.
Schlingemann, R. O., Dingjan, G. M., Emeis, J. J., Blok, J., Warnaar, S. O., and Ruiter, D. J. (1985) Monoclonal antibody PAL-E specific for endothelium. Lab. Invest. 52, 71–76.
Koch, A. E., Harlow, L. A., Haines, G. K., Amento, E. P., Unemori, E. N., Wong, W. L., (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol. 152, 4149–4156.
Fregene, T. A., Khanuja, P. S., Gimotty, P. A., Kellogg, C., George, J., and Pienta, K. J. (1994) The relationship of microvessel counts to tumor size, estrogen receptor status, lymph node metastasis, and disease-free survival in patients with stage I and II breast cancer. Int. J. Oncol. 5, 1437–1445.
Bevilacqua, P., Barbareschi, M., Verderio., P., Boracchi, P., Caffo, O., Dalla Palma, P., (1994) Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma-results of a multiparametric study. Breast Cancer Res. Treat. 36, 205–217.
Ogawa, Y., Chung, Y., Nakata, B., Takatsuka, S., Maeda, K., (1994) An evaluation of angiogenesis in breast cancer with factor VIII related antigen staining. Proc. Am. Assoc. Cancer Res. 35, 186 (Abstract 1113).
Obermair, A., Kurz, C., Czerwenka, K., Thoma, M., Kaider, A., and Wagner, T. (1995) Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival. Int. J. Cancer 62, 126–131.
Kohlberger, P., Obermair Sliutz, G., Heinzl, H., Koelbl, H., Breitenecker, G., Gitsch, G., and Kainz, C. (1996) Quantitive immunohistochemistry of factor VIII-related antigen in breast carcinoma. Am. J. Clin. Pathol. 105, 705–710.
Simpson, J., Ahn, C., Battifora, H., and Esteban, J. (1996) Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer 77, 2077–2085.
Heinman, R., Ferguson, D., Powers, C., Recant, W., Weichselbaum, R., and Hellman, S. (1996) Angiogenesis as a predictor of long term survival for patients wit node-negative breast cancer. J. Natl. Cancer Inst. 88, 1764–1769.
Goulding, H., Abdul, R. N., Robertson, J. F., Bell, J. A., Elston, C. W., Blarney, R. W., and Ellis, I. O. (1995) Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum. Pathol. 26, 1196–1200.
Morphopoulos, G., Pearson, M., Ryder, W., Howell, A., and Harris, M. (1996) Tumor angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J. Pathol. 180, 44–49.
Bochner, B., Cote, R., Groshen, S., Esrig, D., Freeman, J., Weidner, N., (1995) Tumor angiogenesis is an independent prognostic indicator in invasive transitional cell carcinoma of the bladder. J. Urol. 153, 456A (Abstract 909).
Philip, E., Stephenson, T., and Reed, M. (1996) Prognostic significance of angiogenesis in transitional carcinoma of the human urinary bladder. Br. J. Urol. 77, 352–357.
MacLennan, G. and Bostwick, D. (1995) Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology 46, 27–30.
Frank, R. E., Saclarides, T. J., Leurgans, S., Speziale, N.J., Drab, E. A., and Rubin, D. B. (1995) Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer [see comments]. Ann. Surg. 222, 695–699.
Bossi, P., Viale, G., Lee, A. K., Alfano, R., Coggi, G., and Bosari, S. (1995) Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res. 55, 5049–5053.
Takebayashi, Y., Akiyama, S., Yamada, K., Akiba, S., and Aikou, T. (1996) Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 78, 226–231.
Lindmark, G., Gerdin, B., Sundberg, C., Pahlman, L., Bergstrom, R., and Glimelius, B. (1996) Prognostic significance of the microvessel count in colorectal cancer. J. Clin. Oncol. 14, 461–466.
Engel, C., Bennett, S., Chambers, A., Doig, G., Shimomatsuya, T., Horiuchi, T., (1996) Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am. J. Clin. Pathol. 20, 1260–1265.
Tanigawa, N., Amaya, H., Matsumura, M., Shimomatsuya, T., Horiuchi, T., Muraoka, R., and Iki, M. (1996) Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinoma. Cancer Res. 56, 2671–2676.
Rutgers, J. L., Mattox, T. F., and Vargas, M. P. (1995) Angiogenesis in uterine cervical squamous cell carcinoma. Int. J. Gynecol. Pathol. 14, 114–118.
Kainz, C., Speiser, P., Wanner, C., Obermair, A., Tempfer, C., Sliutz, G., (1995) Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB and IIB. Anticancer Res. 15, 1549–1552.
Kirschner, C., Alanis-Amerzcua, J., Martin, V., Luna, N., Morgan, E., Yang, J., and Yordan, E. (1996) Angiogenesis factor in endometrial carcinoma: a new prognastic indicator? Am. J. Obstet. Gynecol. 174, 1879–1884.
Van Diest, P., Zevering, L., and Baak, J. (1995) Lack of prognostic value of microvessel density counts in FIGO 3 and 4 cisplatinum treated ovarian cancer patients. Pathol. Res. Pract. 191, 25–30.
Gasparini, G., Bonoldi, E., Viale, G., Verderio, P., Boracchi, P., Panizzoni, G., (1996) Prognostic and predictive value of tumor angiogenesis in ovarian carcinomas. Int. J. Cancer 69, 205–211.
Yamazaki, K., Abe, S., Takekawa, H., Sukoh, N., Watanabe, N., Ogura, S., (1994) Tumor angiogenesis in human lung adenocarcinoma. Cancer 74, 2245–2250.
Macchiarini, P., Fontanini, G., Dulmet, E., de Montepreville, V., Chapelier, A., Cerrina, J., (1994) Angiogenesis: an indicator of metastasis in non-small cell lung cancer invading the thoracic inlet. Ann. Thor. Surg. 57, 1534–1539.
Mattem, J., Koomagi, R., Volm, M. (1995) Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas. Int. J. Oncol. 6, 1059–1062.
Fontanini, G., Bigini, D., Vignati, S., Basolo, F., Mussi, A., Lucchi, M., (1995) Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J. Pathol. 177, 57–63.
Angeletti, C., Lucchi, M., Fontanini, G., Mussi, A., Chella, A., Ribechini, A., (1996) Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Cancer 78, 409–415.
Harpole, D. J., Richards, W. G., Herndon, J. N., and Sugarbaker, D. J. (1996) Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann. Thorac. Surg. 61, 1470–1476.
Carrau, R., Barnes, E., Snyderman, C., Petruzzelli, G., Kachman, K., Rueger, R., (1995) Tumor angiogenesis as a predictor of tumor aggressiveness and metastatic potential in squamous carcinomas of the head and neck. Inv. Metastasis 15, 197–202.
Dray, T., Hardin, N., Sofferman, R. (1995) Angiogenesis as a prognostic marker in early head and neck cancer. Ann. Otol. Rhinol. Laryngol. 104, 724–729.
Roychowdhury, D., Tseng, A., Fu, K., Weinberg, V., and Weidner, N. (1996) New prognostic factors in nasopharyngeal carcinoma: tumor angiogenesis and c-erbB-2 expression. Cancer 77, 1419–1226.
Shpitzer, T., Chaimoff, M., Gal, R., Stern, Y., Feinmesser, R., and Segal, K. (1996) Tumor angiogenesis as a prognostic factor in early oral tongue cancer. Arch. Otolaryngol. Head Neck Surg. 122, 865–868.
Graham, C., Rivers, J., Kerbel, R., Stankiewicz, K., and White, W. (1994) Extent of vascularization as a prognostic indicator in thin (0.76 mm) malignant melanomas. Am. J. Pathol. 145, 510–514.
Busam, K., Berwick, M., Blessing, K., Fandrey, K., Kang, S., Karaoli, T.,(1995) Tumor vascularity is not a prognostic factor for malignant melanoma. Am. J. Pathol. 147, 1049–1956.
Leon, S., Folkerth, R., and Black, P. (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77, 362–372.
Wesseling, P., Ruiter, D. J., Burger, P. C., (1994) Quantitative immunohistolgical analysis of the microvasculature in untreated human glioblastoma mutliforme. Computer-assisted image analysis of whole-tumor sections. J. Neurosurg. 81, 902–909.
Ito, T., Kitamura, H., Nakamura, N., Kameda, Y., and Kanisawa, M. (1993) A comparative study of vascular proliferation in brain metastasis of lung carcinomas. Virchows Arch. A Pathol. Anat. Histopathol. 423, 13–17.
Foss, A., Alexander, R., Jefferies, L., Hungerford, J., Harris, A., and Lightman, S. (1996) Microvessel count predicts survival in uveal melanoma. Cancer Res. 56, 2900–2903.
Pluda, J. and Parkinson, D. (1996) Clinical implications of tumor-assiciated neovascularization and current anti-angiogenic strategies for the treatment of malignancies of pancreas. Cancer 78, 680–687.
Hellstrom, A., Frankendal, B., Nilsson, B., Pettersson, F., Silfversward, C., and Auer, C. (1996) Primary fallopian tube carcinoma-the prognostic impact of stage, histopathology, and biological parameters. Int. J. Gynecol Cancer 6, 456–462.
Liu, Q., Djuricin, G., Staren, E., Gattuso, P., Gould, V., and Shen, J. (1996) Tumor angiogenesis in phaeochromocytomas and paragangliomas. Surgery 120, 938–942.
Sulh, M., Greco, M., Jiang, T., Goswani, S., Present, D., and Steiner, G. (1996) Proliferation index and vascular density of giant cell tumors of bone. Cancer 77, 2044–2051.
Meitar, D., Crawford, S., Rademaker, A., and Cohn, S. (1996) Tumor angiogenesis correlates with metastatic disease, n-myc amplification and poor outcome in human neuroblastoma. J. Clin. Oncol. 14, 405–414.
Vacca, A., Ribatti, D., Roncali, L., Ranieri, G., Serio, G., Silvestris, F., and Dammacco, F. (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br. J. Haematol. 87, 503–508.
Segal, K., Shpitzer, T., Feinmesser, M., Stern, Y., and Feinmesser, R. (1996) Angiogenesis in follicular tumors of the thyroid. J. Surg. Oncol. 63, 95–98.
Fontanini, G., Vignati, S., Pollina, L., and Basolo, F. (1996) Microvessel count: an indicator of poor outcome in medullary thryroid carcinoma, but not in other types of thyroid carcinoma. Mod. Pathol. 9, 636–841.
Staibano, S., Boscaino, A., Salvatore, G., Orabona, P., Palombini, L., and De Rosa, G. (1996) The prognostic significance of tumor angiogenesis in nonaggessive and aggressive basal cell carcinoma of the human skin. Human Pathol. 27, 695–700.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fox, S.B., Harris, A.L. (2002). Diagnostic and Prognostic Significance of Tumor Angiogenesis. In: Fan, TP.D., Kohn, E.C. (eds) The New Angiotherapy. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-126-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-59259-126-8_10
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9657-4
Online ISBN: 978-1-59259-126-8
eBook Packages: Springer Book Archive